Acceleron Pharma Inc EPS Q / Q
¿Qué es el EPS Q / Q de Acceleron Pharma Inc?
El EPS Q / Q de Acceleron Pharma Inc es 75.76%
¿Cuál es la definición de EPS Q / Q?
La tasa de crecimiento trimestral del EPS, trimestre a trimestre , es el aumento del EPS de la compañía en los últimos 4 trimestres en comparación con el comportamiento de los 4 trimestres anteriores.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Acceleron Pharma Inc
¿Qué hace Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Empresas con eps q / q similar a Acceleron Pharma Inc
- Banco Latinoamericano De Comercio Exterior SA tiene EPS Q / Q de 75.00%
- Saia tiene EPS Q / Q de 75.21%
- Lumax Industries tiene EPS Q / Q de 75.22%
- Cross Country Healthcares tiene EPS Q / Q de 75.41%
- Constellation Software tiene EPS Q / Q de 75.42%
- Univar Solutions Inc tiene EPS Q / Q de 75.44%
- Acceleron Pharma Inc tiene EPS Q / Q de 75.76%
- NIC Inc tiene EPS Q / Q de 76.19%
- Arch Resources Inc tiene EPS Q / Q de 76.42%
- Personalis Inc tiene EPS Q / Q de 76.47%
- Windtree Therapeutics tiene EPS Q / Q de 76.74%
- LPL Inc tiene EPS Q / Q de 76.84%
- Vaxart Inc tiene EPS Q / Q de 76.92%